TANDEM DIABETES CARE, INC.
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
Tandem Freedom - Feasibility Trial 2
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2025-02-19
- Last Posted Date
- 2025-04-15
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06834568
- Locations
- π³πΏ
University of Otago, Christchurch, New Zealand
PS230005 Control-IQ 1.5 Post-Approval Study
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2024-12-05
- Last Posted Date
- 2025-02-04
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06717451
- Locations
- πΊπΈ
Tandem Diabetes Care, San Diego, California, United States
Tandem Freedom - Feasibility Trial 1
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2024-05-24
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT06428591
- Locations
- π³πΏ
University of Otago, Christchurch, New Zealand
Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes
- Conditions
- Type1diabetes
- Interventions
- Device: SteadiSet Extended Wear Infusion Set
- First Posted Date
- 2024-02-22
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 260
- Registration Number
- NCT06273124
- Locations
- πΊπΈ
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
πΊπΈStanford University, Stanford, California, United States
πΊπΈBarbara Davis Center, Aurora, Colorado, United States
Sigi Insulin Management System - A First-in-Human Study in Adults With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- Interventions
- Device: SIGI Insulin Management System
- First Posted Date
- 2023-08-02
- Last Posted Date
- 2024-01-11
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT05973422
A Randomized Trial Evaluating Control-IQ Technology in Adults With Type 2 Diabetes
- Conditions
- Type 2 Diabetes Treated With Insulin
- Interventions
- Device: Standard Therapy plus continuous glucose monitoring (CGM)
- First Posted Date
- 2023-03-27
- Last Posted Date
- 2024-10-04
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 319
- Registration Number
- NCT05785832
- Locations
- πΊπΈ
Hoag Memorial Hospital Presbyterian, Newport Beach, California, United States
πΊπΈEmory University School of Medicine, Atlanta, Georgia, United States
πΊπΈNorthwestern University, Chicago, Illinois, United States
Use of Control-IQ Technology 2.0 in Adults, Children, and Preschoolers With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT05683392
- Locations
- πΊπΈ
Barbara Davis Center, Aurora, Colorado, United States
πΊπΈBarbara Davis Center (Pediatric Clinic), Aurora, Colorado, United States
πΊπΈUniversity of Virginia, Charlottesville, Virginia, United States
Control-IQ Technology for High Insulin Users With Type 1 Diabetes (Higher-IQ)
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2022-06-16
- Last Posted Date
- 2025-04-03
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 34
- Registration Number
- NCT05422053
- Locations
- πΊπΈ
International Diabetes Center, Minneapolis, Minnesota, United States
πΊπΈRocky Mountain Diabetes Center, Idaho Falls, Idaho, United States
πΊπΈBarbara Davis Center, Aurora, Colorado, United States
Safety Evaluation of an Advanced Hybrid Closed Loop System Using Lyumjev With the Tandem t:Slim X2 Insulin Pump With Control-IQ Technology in Adults, Adolescents and Children With Type 1 Diabetes
- Conditions
- Type 1 Diabetes
- First Posted Date
- 2022-06-03
- Last Posted Date
- 2024-07-26
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 183
- Registration Number
- NCT05403502
- Locations
- πΊπΈ
Stanford University, Palo Alto, California, United States
πΊπΈIcahn School of Medicine at Mt. Sinai, New York, New York, United States
πΊπΈChildren's Hospital Orange County, Orange, California, United States
Adaptation of Insulin Delivery Settings to Improve Clinical Outcomes With AID Use
- Conditions
- Type 1 Diabetes
- Interventions
- Device: Automated Insulin Delivery Settings Initialization and Adaptation Algorithm
- First Posted Date
- 2022-01-24
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- Tandem Diabetes Care, Inc.
- Target Recruit Count
- 33
- Registration Number
- NCT05204134
- Locations
- πΊπΈ
Barbara Davis Center, Aurora, Colorado, United States